Skip to content

Clinical trials

Phase 3 Heart Failure trials in India

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Failure Phase: Phase 3 Country / region: India Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20063
20073
20081
20091
20143
20175
20191
20201
20231
20245
20252
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Recruiting8
Terminated4
Active, not recruiting1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
AstraZeneca4
Boehringer Ingelheim4
Novo Nordisk A/S3
Colorado Prevention Center2
Amgen1
Bayer1
Biogen1
Boston Scientific Corporation1
CardioKine Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Failure29
Cardiovascular Diseases2
Anemia1
Bundle-Branch Block1
Cognitive Dysfunction1
Coronary Artery Disease1
Diabetes Mellitus, Type 21
Dyspnea1
Edema1
Heart Diseases1

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.